Merck & Company Inc. (NYSE: MRK) stock closed at 108.61 per share at the end of the most recent trading day (a -1.27% change compared to the prior day closing price) with a volume of 11.64M shares and market capitalization of 279.55B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 74000 people. Merck & Company Inc. CEO is Robert M. Davis.

The one-year performance of Merck & Company Inc. stock is 21.38%, while year-to-date (YTD) performance is -2.11%. MRK stock has a five-year performance of 73.55%. Its 52-week range is between 83.05 and 119.65, which gives MRK stock a 52-week price range ratio of 74.10%

Merck & Company Inc. currently has a PE ratio of 19.10, a price-to-book (PB) ratio of 6.55, a price-to-sale (PS) ratio of 6.16, a price to cashflow ratio of 14.80, a PEG ratio of 2.32, a ROA of 16.38%, a ROC of 23.41% and a ROE of 40.81%. The company’s profit margin is 25.32%, its EBITDA margin is 36.70%, and its revenue ttm is $45.45 Billion , which makes it $17.93 revenue per share.

Of the last four earnings reports from Merck & Company Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.85 for the next earnings report. Merck & Company Inc.’s next earnings report date is 27th Jul 2023.

The consensus rating of Wall Street analysts for Merck & Company Inc. is Strong Buy (1.44), with a target price of $115.93, which is +5.22% compared to the current price. The earnings rating for Merck & Company Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Merck & Company Inc. has a dividend yield of 2.65% with a dividend per share of $2.92 and a payout ratio of 104.00%.

Merck & Company Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 8.82, ATR14 : 2.32, CCI20 : -151.44, Chaikin Money Flow : -0.09, MACD : -1.20, Money Flow Index : 41.52, ROC : -5.96, RSI : 35.58, STOCH (14,3) : 17.04, STOCH RSI : 0.27, UO : 43.80, Williams %R : -82.96), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Merck & Company Inc. in the last 12-months were: David Michael Williams (Option Excercise at a value of $128 598), Jannie Oosthuizen (Option Excercise at a value of $184 006), Jannie Oosthuizen (Sold 54 622 shares of value $5 445 371 ), Jennifer Zachary (Option Excercise at a value of $4 227 433), Jennifer Zachary (Sold 240 691 shares of value $24 205 655 ), Joseph Romanelli (Sold 5 000 shares of value $541 101 ), Kenneth C. Frazier (Option Excercise at a value of $0), Kenneth C. Frazier (Sold 2 172 853 shares of value $216 848 622 ), Richard R. DeLuca (Option Excercise at a value of $0), Richard R. DeLuca (Sold 164 557 shares of value $16 499 094 ), Rita A. Karachun (Option Excercise at a value of $0), Rita A. Karachun (Sold 31 997 shares of value $3 210 684 ), Robert M. Davis (Option Excercise at a value of $0), Robert M. Davis (Sold 167 613 shares of value $17 169 839 ), Sanat Chattopadhyay (Option Excercise at a value of $12 368 125), Sanat Chattopadhyay (Sold 250 449 shares of value $27 084 010 ), Steven C. Mizell (Option Excercise at a value of $0), Steven C. Mizell (Sold 71 251 shares of value $7 227 494 )